Altimmune Inc

Altimmune Inc is an American clinical-stage biopharmaceutical company focused on developing innovative treatments. Its primary aim is to address significant unmet medical needs in areas such as obesity, liver diseases and infectious diseases. The company is involved in clinical trials to advance its pipeline candidates. Operating within the healthcare sector, Altimmune Inc concentrates on novel peptide-based therapeutics. Its research aims to develop therapies designed to provide improved outcomes for patients suffering from chronic and life-threatening conditions by targeting specific biological pathways. Keep up to date on the latest share price changes by adding ALT stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.